Carlsmed Is Betting on AI-Driven Data to Personalize Spine Surgery
By combining advances in AI and machine learning, image data extraction, and 3D printing, Carlsmed believes it can bring precision medicine to spine surgery. Investors supported the company’s strategy with a $52.5 million Series C.